Oxelmark L - Search Results

1

Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.

Sjöqvist U, Tribukait B, Ost A, Einarsson C, Oxelmark L, Löfberg R. Sjöqvist U, et al. Among authors: oxelmark l. Anticancer Res. 2004 Sep-Oct;24(5B):3121-7. Anticancer Res. 2004. PMID: 15510599 Free article. Clinical Trial.

2

Anxiety, functional health status, and coping ability in patients with ulcerative colitis who are undergoing colonoscopic surveillance.

Oxelmark L, Nordström G, Sjöqvist U, Löfberg R. Oxelmark L, et al. Inflamm Bowel Dis. 2004 Sep;10(5):612-7. doi: 10.1097/00054725-200409000-00017. Inflamm Bowel Dis. 2004. PMID: 15472523

3

Group-based intervention program in inflammatory bowel disease patients: effects on quality of life.

Oxelmark L, Magnusson A, Löfberg R, Hillerås P. Oxelmark L, et al. Inflamm Bowel Dis. 2007 Feb;13(2):182-90. doi: 10.1002/ibd.20061. Inflamm Bowel Dis. 2007. PMID: 17206698 Clinical Trial.

4

Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresis.

Oxelmark L, Hillerås P, Dignass A, Mössner J, Schreiber S, Kruis W, Löfberg R. Oxelmark L, et al. Scand J Gastroenterol. 2007 Mar;42(3):406-7. doi: 10.1080/00365520600881060. Scand J Gastroenterol. 2007. PMID: 17354122 Clinical Trial. No abstract available.

5

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.

Oxelmark L, Lindberg A, Löfberg R, Sternby B, Eriksson A, Almer S, Befrits R, Fossum B, Karlén P, Broström O, Tysk C; SOIBD, the Swedish Organization for the study of Inflammatory Bowel Disease. Oxelmark L, et al. Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1320-8. doi: 10.1097/MEG.0000000000000710. Eur J Gastroenterol Hepatol. 2016. PMID: 27472271 Free PMC article. Clinical Trial.

6

Experiences of complementary and alternative medicine in patients with inflammatory bowel disease - a qualitative study.

Lindberg A, Fossum B, Karlen P, Oxelmark L. Lindberg A, et al. Among authors: oxelmark l. BMC Complement Altern Med. 2014 Oct 22;14:407. doi: 10.1186/1472-6882-14-407. BMC Complement Altern Med. 2014. PMID: 25338541 Free PMC article.

7

Support and continuity during the first 2 weeks postpartum.

Barimani M, Oxelmark L, Johansson SE, Hylander I. Barimani M, et al. Among authors: oxelmark l. Scand J Caring Sci. 2015 Sep;29(3):409-17. doi: 10.1111/scs.12144. Epub 2014 Apr 28. Scand J Caring Sci. 2015. PMID: 24773157

8

Professional support and emergency visits during the first 2 weeks postpartum.

Barimani M, Oxelmark L, Johansson SE, Langius-Eklöf A, Hylander I. Barimani M, et al. Among authors: oxelmark l. Scand J Caring Sci. 2014 Mar;28(1):57-65. doi: 10.1111/scs.12036. Epub 2013 Mar 15. Scand J Caring Sci. 2014. PMID: 23488544

9

Inflammatory bowel disease professionals' attitudes to and experiences of complementary and alternative medicine.

Lindberg A, Ebbeskog B, Karlen P, Oxelmark L. Lindberg A, et al. Among authors: oxelmark l. BMC Complement Altern Med. 2013 Dec 10;13:349. doi: 10.1186/1472-6882-13-349. BMC Complement Altern Med. 2013. PMID: 24325595 Free PMC article.

10

[Reduced quality of life during attacks lays the foundation for alternative therapy].

Hjortswang H, Oxelmark L. Hjortswang H, et al. Among authors: oxelmark l. Lakartidningen. 2009 Nov 4-12;106(45):3010-3. Lakartidningen. 2009. PMID: 19998828 Review. Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page